Home/Directory/Real-World Evidence & HEOR/Pedestal Health (formerly Target RWE)

Pedestal Health (formerly Target RWE)

Durham, NC · United States

Real-World Evidence & HEORmid

Specialization: Longitudinal patient cohorts and regulatory-grade RWE

Key Differentiator

Runs deeply phenotyped, prospectively designed patient cohorts in hepatology, dermatology and gastroenterology.

Core Services

Prospective longitudinal cohorts; Regulatory-grade real-world evidence; Label expansion evidence; Post-approval safety and effectiveness studies

Capabilities

Disease cohort and registry operationsEvidence for regulatory submissionsPost approval safety and effectiveness studiesQuantitative sciences and analytics

Market Intelligence

Highlander Health acquired Target RWE in January 2025; the company now operates as Pedestal Health. Co-CEOs are Amy Abernethy and Brad Hirsch.

Website

www.pedestalhealth.com

Similar Companies

Evidera (PPD/Thermo Fisher)

Bethesda, MD; global · Health economics, outcomes research, RWE

Premier HEOR/RWE specialist

Broadstreet HEOR

Vancouver, BC · Health economics and evidence synthesis consultancy

Builds custom economic models and evidence packages for HTA agencies and payers across the drug life cycle.

Medlior

Calgary, AB · Independent RWE and HTA research consultancy

Independent Canadian consultancy with deep experience using Alberta real-world data.

PeriPharm

Montréal, QC · Pharmacoeconomics and market access consulting

Montréal firm focused on Canadian payer submissions, including INESSS and CDR.

Need help finding the right outsourcing partner?

Try AI Navigator

Company information is sourced from publicly available data and may not be current. PharmoniQ does not endorse any company listed. Contact companies directly for the most up-to-date information.